EUDAW Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- —
- P/S (TTM)
- —
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- 0.0%
- Operating margin
- -34.8%
- Revenue growth YoY
- 78.9%
- Dividend yield
- —
- Beta
- 0.64
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About EUDA Health Holdings Limited
Company profileEUDA Health Holdings Limited is a pioneering biotechnology firm dedicated to developing cutting-edge therapies for dermatological and chronic health conditions. With a strong emphasis on scientific innovation and technological integration, EUDA is committed to addressing significant unmet medical needs through its comprehensive pipeline of transformative products. Backed by a seasoned leadership team with extensive industry experience, the company is well-positioned to capitalize on growth opportunities in the rapidly evolving healthcare landscape, ultimately aimed at improving patient…
Classification
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 60 KAKI BUKIT PLACE, SINGAPORE, SINGAPORE
- Fiscal year end
- December
- Latest quarter
- Sep 30, 2025
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer